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The study by Dulcey and colleagues in this issue of Chemistry & Biology changes our perception of
the pathway of 2-alkyl-4-hydroxyquinoline biosynthesis by the opportunistic pathogen Pseudomonas
aeruginosa and suggests that the biosynthetic protein complex PqsBC is a potential antibacterial target.Pseudomonas aeruginosa, a major
opportunistic pathogen, produces a
wide array of bioactive secondary metab-
olites. Among these are more than 50 4-
hydroxy-2-alkylquinolines (HAQs), which
differ in the presence or absence of a
hydroxyl substituent at the 3-position, in
the length of the 2-alkyl or -alkenyl side
chain, and in the presence of an N-oxide
group in place of the quinoline nitrogen
(Le´pine et al., 2004). 2-heptyl-3,4-
dihydroxyquinoline (2-heptyl-3-hydroxy-
4(1H)-quinolone), termed the ‘‘Pseudo-
monas quinolone signal’’ (PQS), as well
as its biosynthetic precursor 2-heptyl-4-
hydroxyquinoline (HHQ) act as signaling
molecules in quorum sensing, a cell-
to-cell communication mechanism that
enables bacteria to synchronize their
behavior in a growth- and cell-density-
dependent manner (reviewed, e.g., by
Heeb et al., 2011). Because PQS signaling
significantly contributes to the regula-
tion of virulence gene expression in
P. aeruginosa, the HAQ quorum sens-
ing system is an attractive antibacte-
rial target. Therefore, understanding the
HAQ biosynthetic pathway, which has
been unraveled in the study by Dulcey
et al. (2013) in this issue of Chemistry &
Biology, not only advances our knowl-
edge of microbial metabolism and
biochemistry, but also contributes to the
identification of potential targets to inter-
fere with quorum sensing and thus to con-
trol virulence.
Whereas the significance of PQS and
HHQ as signaling molecules was recog-
nized around the turn of the 21st century,
HAQs were originally identified as antibi-
otic substances. Studies on antibacterial
agents released by P. aeruginosa actu-
ally date back to the late 19th century.
They were probably inspired by the
observation of Louis Pasteur that ani-
mals injected with a mixture of Bacillus1438 Chemistry & Biology 20, December 19,anthracis and certain other bacteria
failed to develop anthrax. Emmerich and
Lo¨w (1899) used concentrated cell-free
culture fluid of Bacillus pyocyaneus
(P. aeruginosa) to prevent anthrax in in-
fected rabbits. They thought that the
active agent released by B. pyocyaneus
was an enzyme and thus called it pyocya-
nase. However, isolation of the antibac-
terial substance by Hays et al. (1945)
revealed that it consisted of several
structurally related organic compounds,
which—‘‘for historical reasons’’—were
named Pyo I–IV. A few years later, the
structure of three Pyo compounds was
verified by synthesis. A hypothesis on
the biosynthetic pathway was first put
forward in 1956 by Cornforth and James,
who pointed out that ‘‘the structure
of the known Pyo compounds (.) sug-
gests a plausible mode of biosynthesis.
Condensation of anthranilic acid with a
b-keto fatty acid intermediate (.) could
lead, with loss of carbon dioxide and
water, directly to a Pyo compound’’
(Cornforth and James, 1956). To test
this hypothesis versus the alternative as-
sumptions that biosynthesis might pro-
ceed via kynurenic acid or via 2,4-dihy-
droxyquinoline (DHQ), Ritter and Luckner
(1971) fed isotope-labeled potential pre-
cursors to P. aeruginosa. Analysis of
HAQ degradation products, obtained by
ozonization, permitted localization of the
labeled atoms as illustrated in Figure 1A.
Ritter and Luckner (1971) as well as Bre-
denbruch et al. (2005) observed that
b-keto fatty acids can be used for HAQ
biosynthesis; however, the fate of the
carbons, especially those at positions 1
through 3, was not analyzed. Considering
known enzymatic reactions of the primary
metabolism, Ritter and Luckner proposed
a ‘‘likely pathway’’ of HAQ biosynthesis
from anthraniloyl-coenzyme A and b-ke-
toacyl-CoA.2013 ª2013 Elsevier Ltd All rights reservedThis long-standing hypothesis, which,
due to its alluring plausibility, has been
readily adopted, is challenged in the
new study by Dulcey et al. (2013). One of
their key experiments involved the feeding
of labeled decanoic acid to P. aeruginosa,
which, according to the ‘‘old’’ hypothesis,
should undergo b-oxidation to b-ketode-
canoic acid, followed by condensation
with activated anthranilic acid and loss
of the C1 carbon of the b-ketodeca-
noic acid as CO2. While the five deute-
rium atoms of [9,9,10,10,10-2H5]decanoic
acid were incorporated into HHQ,
labeling of HHQ with one 13C from
[1,2-13C2]decanoate was not observed
(Figure 1B).
HAQs derive from a common bio-
synthetic pathway, which requires the
PqsABCD proteins. Hydroxylation at C-3
of HAQ is catalyzed by PqsH, and synthe-
sis of HAQ-N-oxides involves the PqsL
protein besides PqsABCD. Whereas
PqsA and PqsD were characterized as
anthranilate CoA ligase and condensing
enzyme, respectively (Figure 1A), the
roles of PqsB and PqsC remained
unclear. To find out whether formation
of the quinoline ring occurs stepwise,
involving a yet unidentified intermediate,
Dulcey et al. (2013) took a classical micro-
biological approach and performed elab-
orate cross-feeding experiments using
sterilized supernatants of a series of
P. aeruginosa mutants defective in indi-
vidual pqs genes. The culture supernatant
of pqsB or pqsC strains when fed to a
pqsA or pqsD mutant resulted in HAQ
production by the latter mutants, so the
pqsB and pqsCmutants must produce
an intermediate that, in the pathway, is
downstreamof the PqsA- and PqsD-cata-
lyzed reactions. The authors managed to
isolate and identify the new intermediate,
which is quite unstable, as 2-aminoben-
zoylacetate (2-ABA). Chemical synthesis
Figure 1. The Long-Standing ‘‘Old’’ Hypothesis on the Biosynthesis of HHQ versus the New Pathway Proposed by Dulcey et al. (2013)
(A and B) The upper parts in (A) and (B) illustrate isotope labeling experiments reported by Ritter and Luckner (1971) and Dulcey et al. (2013), respectively. The
lower part of (A) summarizes the ‘‘old’’ hypothetical pathway and indicates the roles of PqsABCD in HAQ biosynthesis (reviewed, e.g., by Heeb et al., 2011); the
lower part of (B) shows the pathway of HHQ synthesis as supported by the data of Dulcey et al. (2013). 2-ABA, 2-aminobenzoylacetate; ACP, acyl carrier protein;
CoA, coenzyme A; DHQ, 2,4-dihydroxyquinoline; HHQ, 2-heptyl-4-hydroxyquinoline (2-heptyl-4(1H)-quinolone).
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(see Figure 1B) verified its activity
as pathway intermediate. When [2-13C]
acetate was a precursor of in vivo biosyn-
thesis of 2-ABA, the HHQ formed from the
intermediate carried the 13C label. This
was not the case if [1-13C]acetate was
fed to the 2-ABA producer. Experiments
with cell extracts suggested that ma-
lonyl-CoA (rather than acetyl-CoA) is the
precursor for condensation with activated
anthranilic acid. Feeding 2-ABA-contain-
ing culture supernatant together with
fully 13C-labeled acetate or octanoate to
P. aeruginosa PA14 (pqsA pqsH) re-
vealed that the heptyl side chain together
with C2 of the ring can derive directly fromoctanoate or from de novo fatty acid
biosynthesis (Figure 1B). The authors,
moreover, performed biochemical studies
in order to analyze the functions of PqsB
and PqsC. They observed that coexpres-
sion of PqsC and PqsB is required to pro-
duce soluble protein, which purifies as
a stable PqsBC complex. PqsC loading
with an octanoyl moiety was shown by
peptide mass spectrometry, and PqsBC
was proven to be sufficient to catalyze
the formation of HHQ from octanoyl-CoA
and 2-ABA.
The systematic study of Dulcey et al.
(2013) changes our perception of HAQ
synthesis and draws attention to the
PqsBC complex as potential drug target.Chemistry & Biology 20, December 19, 2013However, some questions still remain to
be explored. Considering that it catalyzes
the condensation of anthraniloyl-CoAwith
b-ketodecanoic acid in vitro, albeit with a
very poor catalytic efficiency (Steinbach
et al., 2013), how promiscuous is PqsD?
Moreover, a recent report on the intercep-
tion of octanoyl-CoA by a specific 3-ox-
oacyl-ACP synthase, which forms b-keto
decanoyl-ACP for shunting it into fatty
acid biosynthesis (Yuan et al., 2012),
poses the question of whether regulatory
mechanisms govern the in vivo distribu-
tion of octanoyl-CoA. In the new pathway
(Figure 1B), is 2-ABA indeed the direct
substrate of PqsBC, and if so, which
enzyme catalyzes the release of theª2013 Elsevier Ltd All rights reserved 1439
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Previewacid from a thioester intermediate? Is the
formation of 2,4-DHQ and 2-aminoaceto-
phenone by P. aeruginosa just an ‘‘acci-
dent’’ due to the strong tendency of (acti-
vated) 2-ABA to decompose? What is the
exact role of PqsB, which belongs to the
same protein family as PqsD and PqsC,
but lacks the conserved amino acid resi-
dues presumed to be essential for the cat-
alytic activity of condensing enzymes?
And which of the pathway intermediates
is the physiological substrate of PqsL
that is required for the synthesis of
HAQ-N-oxides? Things certainly remain
exciting.1440 Chemistry & Biology 20, December 19,REFERENCES
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